ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.”

July 18, 2008

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

AACI Summarizes Position On New Core Guidelines

May 16, 1980

In Congress: NCI Defends Role of Advisor In Response To House Inquiry

September 19, 1997

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

May 11, 2012